{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T07:20:22Z","timestamp":1790666422706,"version":"4.1.0"},"reference-count":81,"publisher":"Portland Press Ltd.","issue":"9","license":[{"start":{"date-parts":[[2019,9,27]],"date-time":"2019-09-27T00:00:00Z","timestamp":1569542400000},"content-version":"vor","delay-in-days":26,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["portlandpress.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2019,9,30]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Hepatoblastoma is a malignant tumor in the liver of children that generally occurs at the age of 2\u20133 years. There have been ample evidence from the preclinical as well as clinical studies suggesting the activation of Wnt\/\u03b2-catenin signaling in hepatoblastoma, which is mainly attributed to the somatic mutations in the exon 3 of \u03b2-catenin gene. There is increased translocation of \u03b2-catenin protein from the cell surface to cytoplasm and nucleus and intracellular accumulation is directly linked to the severity of the cancer. Accordingly, the alterations in \u03b2-catenin and its target genes may be used as markers in the diagnosis and prognosis of pediatric live tumors. Furthermore, scientists have reported the therapeutic usefulness of inhibition of Wnt\/\u03b2-catenin signaling in hepatoblastoma and this inhibition of signaling has been done using different methods including short interfering RNA (siRNA), miRNA and pharmacological agents. Wnt\/\u03b2-catenin works in association with other signaling pathways to induce the development of hepatoblastoma including Yes-associated protein (YAP)1 (YAP-1), mammalian target of rapamycin (mTOR) 1 (mTOR-1), SLC38A1, glypican 3 (GPC3), nuclear factor \u03ba-light-chain-enhancer of activated B cells (NF-kB), epidermal growth factor receptor, ERK1\/2, tumor necrosis factor-\u03b1 (TNF-\u03b1), regenerating islet-derived 1 and 3 \u03b1 (REG1A and 3A), substance P (SP)\/neurokinin-1 receptor and PARP-1. The present review describes the key role of Wnt\/\u03b2-catenin signaling in the development of hepatoblastoma. Moreover, the role of other signaling pathways in hepatoblastoma in association with Wnt\/\u03b2-catenin has also been described.<\/jats:p>","DOI":"10.1042\/bsr20192466","type":"journal-article","created":{"date-parts":[[2019,9,11]],"date-time":"2019-09-11T19:44:07Z","timestamp":1568231047000},"update-policy":"https:\/\/doi.org\/10.1042\/crossmark_policy","source":"Crossref","is-referenced-by-count":47,"title":["Wnt\/\u03b2-catenin signaling as a useful therapeutic target in hepatoblastoma"],"prefix":"10.1042","volume":"39","author":[{"given":"Ying-Li","family":"Sha","sequence":"first","affiliation":[{"name":"Department of Pediatric, The First Hospital of Jilin University-The Eastern Division, Changchun, Jilin, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuang","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Nursing Management, The First Hospital of Jilin University-The Eastern Division, Changchun, Jilin, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-Wen","family":"Yan","sequence":"additional","affiliation":[{"name":"Department of Pediatric, The First Hospital of Jilin University-The Eastern Division, Changchun, Jilin, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4531-8165","authenticated-orcid":false,"given":"Bo","family":"Dong","sequence":"additional","affiliation":[{"name":"Department of Pediatric, The First Hospital of Jilin University-The Eastern Division, Changchun, Jilin, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"288","published-online":{"date-parts":[[2019,9,24]]},"reference":[{"key":"2021111619493513000_B1","doi-asserted-by":"publisher","first-page":"53","DOI":"10.12688\/f1000research.12239.1","article-title":"Hepatoblastoma: current understanding, recent advances, and controversies","volume":"7","author":"Czauderna","year":"2018","journal-title":"F1000Res."},{"key":"2021111619493513000_B2","doi-asserted-by":"publisher","first-page":"480","DOI":"10.2741\/e393","article-title":"Activation of Wnt and Myc signaling in hepatoblastoma","volume":"4","author":"Cairo","year":"2012","journal-title":"Front. Biosci. (Elite Ed.)"},{"key":"2021111619493513000_B3","doi-asserted-by":"publisher","first-page":"4863","DOI":"10.1038\/sj.onc.1205591","article-title":"Mutational spectrum of \u03b2-catenin, AXIN1, and AXIN2 in hepatocellular carcinomas and hepatoblastomas","volume":"21","author":"Taniguchi","year":"2002","journal-title":"Oncogene"},{"key":"2021111619493513000_B4","doi-asserted-by":"publisher","first-page":"2221","DOI":"10.1016\/j.jpedsurg.2011.09.003","article-title":"Wnt signaling and telomerase activation of hepatoblastoma: correlation with chemosensitivity and surgical resectability","volume":"46","author":"Ueda","year":"2011","journal-title":"J. Pediatr. Surg."},{"key":"2021111619493513000_B5","doi-asserted-by":"publisher","first-page":"e320","DOI":"10.1097\/MPH.0b013e3182580471","article-title":"Relationship of \u03b2-catenin and postchemotherapy histopathologic changes with overall survival in patients with hepatoblastoma","volume":"34","author":"Gupta","year":"2012","journal-title":"J. Pediatr. Hematol. Oncol."},{"key":"2021111619493513000_B6","doi-asserted-by":"publisher","first-page":"1589","DOI":"10.15252\/emmm.201707814","article-title":"Mutant CTNNB1 and histological heterogeneity define metabolic subtypes of hepatoblastoma","volume":"9","author":"Crippa","year":"2017","journal-title":"EMBO Mol. Med."},{"key":"2021111619493513000_B7","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1146\/annurev-pathol-020117-044010","article-title":"Wnt\/\u03b2-catenin signaling in liver development, homeostasis, and pathobiology","volume":"13","author":"Russell","year":"2018","journal-title":"Annu. Rev. Pathol."},{"key":"2021111619493513000_B8","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1038\/s41575-018-0075-9","article-title":"Wnt-\u03b2-catenin signalling in liver development, health and disease","volume":"16","author":"Perugorria","year":"2019","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"2021111619493513000_B9","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1007\/s10024-005-0028-5","article-title":"\u03b2-Catenin and met deregulation in childhood hepatoblastomas","volume":"8","author":"Ranganathan","year":"2005","journal-title":"Pediatr. Dev. Pathol."},{"key":"2021111619493513000_B10","first-page":"17","article-title":"Molecular link(s) between hepatoblastoma pathogenesis and exposure to di-(2-ethylhexyl)phthalate: a hypothesis","volume":"50","author":"Salvatore","year":"2008","journal-title":"Folia Med. (Plovdiv)"},{"key":"2021111619493513000_B11","doi-asserted-by":"publisher","first-page":"141","DOI":"10.3727\/105221616X693639","article-title":"Novel advances in understanding of molecular pathogenesis of hepatoblastoma: a Wnt\/\u03b2-Catenin perspective","volume":"17","author":"Bell","year":"2017","journal-title":"Gene Expr."},{"key":"2021111619493513000_B12","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1002\/mpo.10180","article-title":"Genetic alterations in hepatoblastoma and hepatocellular carcinoma: common and distinctive aspects","volume":"39","author":"Buendia","year":"2002","journal-title":"Med. Pediatr. Oncol."},{"key":"2021111619493513000_B13","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1016\/j.ccr.2008.11.002","article-title":"Hepatic stem-like phenotype and interplay of Wnt\/\u03b2-catenin and Myc signaling in aggressive childhood liver cancer","volume":"14","author":"Cairo","year":"2008","journal-title":"Cancer Cell"},{"key":"2021111619493513000_B14","doi-asserted-by":"publisher","first-page":"22789","DOI":"10.1074\/jbc.M112.378224","article-title":"Calpain induces N-terminal truncation of \u03b2-catenin in normal murine liver development: diagnostic implications in hepatoblastomas","volume":"287","author":"Lade","year":"2012","journal-title":"J. Biol. Chem."},{"key":"2021111619493513000_B15","doi-asserted-by":"publisher","first-page":"4515","DOI":"10.1158\/0008-5472.CAN-13-3275","article-title":"\u03b2-catenin activation in a novel liver progenitor cell type is sufficient to cause hepatocellular carcinoma and hepatoblastoma","volume":"74","author":"Mokkapati","year":"2014","journal-title":"Cancer Res."},{"key":"2021111619493513000_B16","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1007\/s00383-017-4115-2","article-title":"Utility of PAS and \u03b2-catenin staining in histological categorisation and prediction of prognosis of hepatoblastomas","volume":"33","author":"Bera","year":"2017","journal-title":"Pediatr. Surg. Int."},{"key":"2021111619493513000_B17","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1038\/sj.onc.1203356","article-title":"Activation of \u03b2-catenin in epithelial and mesenchymal hepatoblastomas","volume":"19","author":"Wei","year":"2000","journal-title":"Oncogene"},{"key":"2021111619493513000_B18","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1016\/j.jfma.2016.09.013","article-title":"Complementary roles of \u03b2-catenin and glutamine synthetase immunostaining in diagnosis of chemotherapy-treated and untreated hepatoblastoma","volume":"116","author":"Huang","year":"2017","journal-title":"J. Formos. Med. Assoc."},{"key":"2021111619493513000_B19","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1002\/1096-9896(2000)9999:9999%3c::AID-PATH804%3e3.0.CO;2-R","article-title":"Nuclear localization of \u03b2-catenin is an important prognostic factor in hepatoblastoma","volume":"193","author":"Park","year":"2001","journal-title":"J. Pathol."},{"key":"2021111619493513000_B20","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1016\/j.humpath.2008.07.022","article-title":"Histologic subtypes of hepatoblastoma are characterized by differential canonical Wnt and Notch pathway activation in DLK+ precursors","volume":"40","author":"L\u00f3pez-Terrada","year":"2009","journal-title":"Hum. Pathol."},{"key":"2021111619493513000_B21","first-page":"901","article-title":"Frequent deletions and mutations of the \u03b2-catenin gene are associated with overexpression of cyclin D1 and fibronectin and poorly differentiated histology in childhood hepatoblastoma","volume":"7","author":"Takayasu","year":"2001","journal-title":"Clin. Cancer Res."},{"key":"2021111619493513000_B22","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1002\/(SICI)1098-2264(199908)25:4%3c399::AID-GCC14%3e3.0.CO;2-X","article-title":"\u03b2-catenin accumulation and mutation of the CTNNB1 gene in hepatoblastoma","volume":"25","author":"Bl\u00e4ker","year":"1999","journal-title":"Genes Chromosomes Cancer"},{"key":"2021111619493513000_B23","first-page":"269","article-title":"Childhood hepatoblastomas frequently carry a mutated degradation targeting box of the beta-catenin gene","volume":"59","author":"Koch","year":"1999","journal-title":"Cancer Res."},{"key":"2021111619493513000_B24","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/S0304-3835(99)00433-4","article-title":"Somatic mutations of \u03b2-catenin play a crucial role in the tumorigenesis of sporadic hepatoblastoma","volume":"152","author":"Jeng","year":"2000","journal-title":"Cancer Lett."},{"key":"2021111619493513000_B25","doi-asserted-by":"publisher","first-page":"1686","DOI":"10.1002\/hep.27243","article-title":"Exome sequencing of hepatoblastoma reveals novel mutations and cancer genes in the Wnt pathway and ubiquitin ligase complex","volume":"60","author":"Jia","year":"2014","journal-title":"Hepatology"},{"key":"2021111619493513000_B26","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.humpath.2017.10.007","article-title":"General paucity of genomic alteration and low tumor mutation burden in refractory and metastatic hepatoblastoma: comprehensive genomic profiling study","volume":"70","author":"Lee","year":"2017","journal-title":"Hum. Pathol."},{"key":"2021111619493513000_B27","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1007\/s003830000576","article-title":"High frequency of \u03b2-catenin mutations in hepatoblastoma","volume":"17","author":"Udatsu","year":"2001","journal-title":"Pediatr. Surg. Int."},{"key":"2021111619493513000_B28","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/j.biocel.2009.07.012","article-title":"Wnt signaling and hepatocarcinogenesis: the hepatoblastoma model","volume":"43","author":"Armengol","year":"2011","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"2021111619493513000_B29","first-page":"551","article-title":"Diagnostic and prognostic impact of \u03b2-catenin alterations in pediatric liver tumors","volume":"15","author":"Yamaoka","year":"2006","journal-title":"Oncol. Rep."},{"key":"2021111619493513000_B30","first-page":"2864","article-title":"\u03b2-catenin mutations and protein accumulation in all hepatoblastomas examined from B6C3F1 mice treated with anthraquinone or oxazepam","volume":"60","author":"Anna","year":"2000","journal-title":"Cancer Res."},{"key":"2021111619493513000_B31","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/S0041-008X(03)00170-4","article-title":"Expression of potential \u03b2-catenin targets, cyclin D1, c-Jun, c-Myc, E-cadherin, and EGFR in chemically induced hepatocellular neoplasms from B6C3F1 mice","volume":"190","author":"Anna","year":"2003","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"2021111619493513000_B32","doi-asserted-by":"publisher","first-page":"e34656","DOI":"10.1371\/journal.pone.0034656","article-title":"Nuclear translocation of \u03b2-catenin during mesenchymal stem cells differentiation into hepatocytes is associated with a tumoral phenotype","volume":"7","author":"Herencia","year":"2012","journal-title":"PLoS ONE"},{"key":"2021111619493513000_B33","doi-asserted-by":"publisher","first-page":"5188","DOI":"10.1074\/jbc.M207216200","article-title":"Identification of the LIM protein FHL2 as a coactivator of \u03b2-catenin","volume":"278","author":"Wei","year":"2003","journal-title":"J. Biol. Chem."},{"key":"2021111619493513000_B34","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1097\/01.LAB.0000059926.66359.BD","article-title":"Overexpression of human Dickkopf-1, an antagonist of wingless\/WNT signaling, in human hepatoblastomas and Wilms\u2019 tumors","volume":"83","author":"Wirths","year":"2003","journal-title":"Lab. Invest."},{"key":"2021111619493513000_B35","doi-asserted-by":"publisher","first-page":"4295","DOI":"10.1158\/1078-0432.CCR-04-1162","article-title":"Elevated expression of Wnt antagonists is a common event in hepatoblastomas","volume":"11","author":"Koch","year":"2005","journal-title":"Clin. Cancer Res."},{"key":"2021111619493513000_B36","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1053\/j.gastro.2014.05.004","article-title":"Activation of \u03b2-catenin and Yap1 in human hepatoblastoma and induction of hepatocarcinogenesis in mice","volume":"147","author":"Tao","year":"2014","journal-title":"Gastroenterology"},{"key":"2021111619493513000_B37","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1016\/j.ajpath.2019.02.002","article-title":"\u03b2-Catenin and Yes-associated protein 1 cooperate in hepatoblastoma pathogenesis","volume":"189","author":"Min","year":"2019","journal-title":"Am. J. Pathol."},{"key":"2021111619493513000_B38","doi-asserted-by":"publisher","first-page":"1475","DOI":"10.18632\/oncotarget.26668","article-title":"mTOR inhibition affects Yap1-\u03b2-catenin-induced hepatoblastoma growth and development","volume":"10","author":"Molina","year":"2019","journal-title":"Oncotarget"},{"key":"2021111619493513000_B39","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1016\/j.ajpath.2019.01.016","article-title":"TEA domain transcription factor 4 is the major mediator of Yes-associated protein oncogenic activity in mouse and human hepatoblastoma","volume":"189","author":"Zhang","year":"2019","journal-title":"Am. J. Pathol."},{"key":"2021111619493513000_B40","doi-asserted-by":"crossref","first-page":"73433","DOI":"10.18632\/oncotarget.20622","article-title":"Central role of mTORC1 downstream of YAP\/TAZ in hepatoblastoma development","volume":"8","author":"Liu","year":"2017","journal-title":"Oncotarget"},{"key":"2021111619493513000_B41","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1111\/his.12730","article-title":"Quantification of glypican 3, \u03b2-catenin and claudin-1 protein expression in hepatoblastoma and paediatric hepatocellular carcinoma by colour deconvolution","volume":"67","author":"Zhou","year":"2015","journal-title":"Histopathology"},{"key":"2021111619493513000_B42","doi-asserted-by":"publisher","first-page":"108","DOI":"10.3389\/fonc.2019.00108","article-title":"Immunotherapeutic targeting of GPC3 in pediatric solid embryonal tumors","volume":"9","author":"Ortiz","year":"2019","journal-title":"Front. Oncol."},{"key":"2021111619493513000_B43","doi-asserted-by":"publisher","first-page":"6536","DOI":"10.1038\/ncomms7536","article-title":"Immunotoxin targeting glypican-3 regresses liver cancer via dual inhibition of Wnt signalling and protein synthesis","volume":"6","author":"Gao","year":"2015","journal-title":"Nat. Commun"},{"key":"2021111619493513000_B44","doi-asserted-by":"publisher","first-page":"41211","DOI":"10.18632\/oncotarget.17162","article-title":"New tumor suppressor microRNAs target glypican-3 in human liver cancer","volume":"8","author":"Cartier","year":"2017","journal-title":"Oncotarget"},{"key":"2021111619493513000_B45","doi-asserted-by":"publisher","first-page":"pii: E82","DOI":"10.3390\/biomedicines6030082","article-title":"Evidence for the involvement of the master transcription factor NF-\u03baB in cancer initiation and progression","volume":"6","author":"Puar","year":"2018","journal-title":"Biomedicines"},{"key":"2021111619493513000_B46","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1007\/s11373-008-9251-1","article-title":"Anti-sense morpholino oligonucleotide assay shows critical involvement for NF-kappaB activation in the production of Wnt-1 protein by HepG2 cells: oncology implications","volume":"15","author":"Sun","year":"2008","journal-title":"J. Biomed. Sci."},{"key":"2021111619493513000_B47","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1053\/j.gastro.2005.04.013","article-title":"Epidermal growth factor receptor: a novel target of the Wnt\/\u03b2-catenin pathway in liver","volume":"129","author":"Tan","year":"2005","journal-title":"Gastroenterology"},{"key":"2021111619493513000_B48","doi-asserted-by":"publisher","first-page":"127","DOI":"10.3892\/mmr.2015.3359","article-title":"Thymosin \u03b24 promotes hepatoblastoma metastasis via the induction of epithelial-mesenchymal transition","volume":"12","author":"Fu","year":"2015","journal-title":"Mol. Med. Rep."},{"key":"2021111619493513000_B49","doi-asserted-by":"publisher","first-page":"1815","DOI":"10.1016\/j.humpath.2012.03.018","article-title":"\u03b2-Catenin mutations in 2 nested stromal epithelial tumors of the liver\u2013a neoplasia with defective mesenchymal-epithelial transition","volume":"43","author":"Assmann","year":"2012","journal-title":"Hum. Pathol."},{"key":"2021111619493513000_B50","doi-asserted-by":"publisher","first-page":"20768","DOI":"10.3390\/ijms141020768","article-title":"Crosstalk between \u03b2-catenin and snail in the induction of epithelial to mesenchymal transition in hepatocarcinoma: role of the ERK1\/2 pathway","volume":"14","author":"Zucchini-Pascal","year":"2013","journal-title":"Int. J. Mol. Sci."},{"key":"2021111619493513000_B51","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1038\/labinvest.3700043","article-title":"Stabilized \u03b2-catenin promotes hepatocyte proliferation and inhibits TNFalpha-induced apoptosis","volume":"84","author":"Shang","year":"2004","journal-title":"Lab. Invest."},{"key":"2021111619493513000_B52","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1038\/sj.onc.1208860","article-title":"Overexpression of regenerating islet-derived 1 alpha and 3 alpha genes in human primary liver tumors with \u03b2-catenin mutations","volume":"25","author":"Cavard","year":"2006","journal-title":"Oncogene"},{"key":"2021111619493513000_B53","doi-asserted-by":"publisher","first-page":"2712","DOI":"10.1158\/1535-7163.MCT-15-0206","article-title":"Targeting the Neurokinin-1 receptor compromises canonical Wnt signaling in hepatoblastoma","volume":"14","author":"Ilmer","year":"2015","journal-title":"Mol. Cancer Ther."},{"key":"2021111619493513000_B54","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1038\/s42003-018-0077-8","article-title":"PARP1 activation increases expression of modified tumor suppressors and pathways underlying development of aggressive hepatoblastoma","volume":"1","author":"Valanejad","year":"2018","journal-title":"Commun. Biol."},{"key":"2021111619493513000_B55","first-page":"715","article-title":"In vitro RNA interference against \u03b2-catenin inhibits the proliferation of pediatric hepatic tumors","volume":"28","author":"Sangkhathat","year":"2006","journal-title":"Int. J. Oncol."},{"key":"2021111619493513000_B56","first-page":"861","article-title":"SiRNA of frizzled-9 suppresses proliferation and motility of hepatoma cells","volume":"35","author":"Fujimoto","year":"2009","journal-title":"Int. J. Oncol."},{"key":"2021111619493513000_B57","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1007\/s00383-012-3237-9","article-title":"Pharmacological inhibition of \u03b2-catenin in hepatoblastoma cells","volume":"29","author":"Ellerkamp","year":"2013","journal-title":"Pediatr. Surg. Int."},{"key":"2021111619493513000_B58","doi-asserted-by":"publisher","first-page":"2111","DOI":"10.1016\/j.ajpath.2014.04.002","article-title":"Identification and characterization of a novel small-molecule inhibitor of \u03b2-catenin signaling","volume":"184","author":"Delgado","year":"2014","journal-title":"Am. J. Pathol."},{"key":"2021111619493513000_B59","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.1080\/01635581.2013.828085","article-title":"Epigallocatechin-3-gallate inhibits hepatoblastoma growth by reactivating the Wnt inhibitor SFRP1","volume":"65","author":"G\u00f6deke","year":"2013","journal-title":"Nutr. Cancer"},{"key":"2021111619493513000_B60","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.yexcr.2014.10.018","article-title":"Anti-tumor activity of sorafenib in a model of a pediatric hepatocellular carcinoma","volume":"331","author":"Nagel","year":"2015","journal-title":"Exp. Cell Res."},{"key":"2021111619493513000_B61","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1002\/hep4.1029","article-title":"MicroRNA therapy inhibits hepatoblastoma growth in vivo by targeting \u03b2-catenin and Wnt signaling","volume":"1","author":"Indersie","year":"2017","journal-title":"Hepatol. Commun."},{"key":"2021111619493513000_B62","doi-asserted-by":"publisher","first-page":"4684","DOI":"10.1111\/bph.13958","article-title":"\u2018Lnc\u2019-ing Wnt in female reproductive cancers: therapeutic potential of long non-coding RNAs in Wnt signalling","volume":"174","author":"Ong","year":"2017","journal-title":"Br. J. Pharmacol."},{"key":"2021111619493513000_B63","doi-asserted-by":"publisher","first-page":"124","DOI":"10.3389\/fphar.2017.00124","article-title":"Breast cancer stem-like cells are inhibited by diosgenin, a steroidal saponin, by the attenuation of the Wnt \u03b2-Catenin signaling via the Wnt antagonist secreted frizzled related protein-4","volume":"8","author":"Bhuvanalakshmi","year":"2017","journal-title":"Front. Pharmacol."},{"key":"2021111619493513000_B64","doi-asserted-by":"publisher","first-page":"pii: E1035","DOI":"10.3390\/cancers11071035","article-title":"Independent negative prognostic role of TCF1 expression within the Wnt\/\u03b2-Catenin signaling pathway in primary breast cancer patients","volume":"11","author":"Saponaro","year":"2019","journal-title":"Cancers (Basel)"},{"key":"2021111619493513000_B65","first-page":"6486","article-title":"Effect of inhibition to Yes-related proteins-mediated Wnt\/\u03b2-catenin signaling pathway through miR-195-5p on apoptosis of gastric cancer cells","volume":"23","author":"Zhao","year":"2019","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"2021111619493513000_B66","first-page":"217","article-title":"ROR1-AS1 promotes tumorigenesis of colorectal cancer via targeting Wnt\/\u03b2-catenin","volume":"23","author":"Liao","year":"2019","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"2021111619493513000_B67","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1186\/s13046-019-1370-1","article-title":"miR-504 suppresses mesenchymal phenotype of glioblastoma by directly targeting the FZD7-mediated Wnt-\u03b2-catenin pathway","volume":"38","author":"Liu","year":"2019","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"2021111619493513000_B68","first-page":"2434","article-title":"Mitofusin 2 inhibits bladder cancer cell proliferation and invasion via the Wnt\/\u03b2-catenin pathway","volume":"18","author":"Pang","year":"2019","journal-title":"Oncol. Lett."},{"key":"2021111619493513000_B69","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1186\/s12885-018-4197-9","article-title":"Phase II trial to investigate the safety and efficacy of orally applied niclosamide in patients with metachronous or sychronous metastases of a colorectal cancer progressing after therapy: the NIKOLO trial","volume":"18","author":"Burock","year":"2018","journal-title":"BMC Cancer"},{"key":"2021111619493513000_B70","doi-asserted-by":"publisher","first-page":"e0171771","DOI":"10.1371\/journal.pone.0171771","article-title":"Effects of exercise training on circulating levels of Dickkpof-1 and secreted frizzled-related protein-1 in breast cancer survivors: a pilot single-blind randomized controlled trial","volume":"12","author":"Kim","year":"2017","journal-title":"PLoS ONE"},{"key":"2021111619493513000_B71","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1038\/bjc.2014.422","article-title":"Negative regulation of signal transducer and activator of transcription-3 signalling cascade by lupeol inhibits growth and induces apoptosis in hepatocellular carcinoma cells","volume":"111","author":"Siveen","year":"2014","journal-title":"Br. J. Cancer"},{"key":"2021111619493513000_B72","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1089\/hum.2018.146","article-title":"STAT3-activated long non-coding RNA lung cancer associated transcript 1 drives cell proliferation, migration, and invasion in hepatoblastoma through regulation of the miR-301b\/STAT3 axis","volume":"30","author":"Wang","year":"2019","journal-title":"Hum. Gene Ther."},{"key":"2021111619493513000_B73","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1111\/boc.201500029","article-title":"The complex role of NOTCH receptors and their ligands in the development of hepatoblastoma, cholangiocarcinoma and hepatocellular carcinoma","volume":"108","author":"Gil-Garc\u00eda","year":"2016","journal-title":"Biol. Cell"},{"key":"2021111619493513000_B74","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.fct.2016.03.013","article-title":"Involvement of PI3K\/Akt, ERK and p38 signaling pathways in emodin-mediated extrinsic and intrinsic human hepatoblastoma cell apoptosis","volume":"92","author":"Cui","year":"2016","journal-title":"Food Chem. Toxicol."},{"key":"2021111619493513000_B75","doi-asserted-by":"publisher","first-page":"45932","DOI":"10.1038\/srep45932","article-title":"Glypican 3 as a serum marker for hepatoblastoma","volume":"7","author":"Zhou","year":"2017","journal-title":"Sci. Rep."},{"key":"2021111619493513000_B76","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/j.tranon.2018.10.008","article-title":"Targeting PIM kinases affects maintenance of CD133 tumor cell population in hepatoblastoma","volume":"12","author":"Stafman","year":"2019","journal-title":"Transl. Oncol."},{"key":"2021111619493513000_B77","doi-asserted-by":"publisher","first-page":"651","DOI":"10.3389\/fphar.2019.00651","article-title":"Lycorine induces mitochondria-dependent apoptosis in hepatoblastoma HepG2 cells through ROCK1 activation","volume":"10","author":"Liu","year":"2019","journal-title":"Front. Pharmacol."},{"key":"2021111619493513000_B78","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1016\/j.humpath.2008.07.022","article-title":"Histologic subtypes of hepatoblastoma are characterized by differential canonical Wnt and Notch pathway activation in DLK+ precursors","volume":"40","author":"Lopez-Terrada","year":"2009","journal-title":"Hum. Pathol."},{"key":"2021111619493513000_B79","doi-asserted-by":"publisher","first-page":"pii: E27","DOI":"10.3390\/cancers11010027","article-title":"Endolysosomal Ca2+ signalling and cancer hallmarks: two-pore channels on the move, TRPML1 lags behind!","volume":"11","author":"Faris","year":"2018","journal-title":"Cancers (Basel)"},{"key":"2021111619493513000_B80","doi-asserted-by":"publisher","first-page":"e27032","DOI":"10.1002\/pbc.27032","article-title":"Down-regulation of dishevelled-2 inhibits cell proliferation and invasion in hepatoblastoma","volume":"65","author":"Huang","year":"2018","journal-title":"Pediatr. Blood Cancer"},{"key":"2021111619493513000_B81","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1293\/tox.2017-0067","article-title":"Spontaneous pulmonary co-metastasis of hepatoblastoma arising within a hepatocellular carcinoma in an aged C57BL\/6J mouse","volume":"31","author":"Castiglioni","year":"2018","journal-title":"J. Toxicol. Pathol."}],"container-title":["Bioscience Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/portlandpress.com\/bioscirep\/article-pdf\/doi\/10.1042\/BSR20192466\/854669\/bsr-2019-2466.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/portlandpress.com\/bioscirep\/article-pdf\/doi\/10.1042\/BSR20192466\/854669\/bsr-2019-2466.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,16]],"date-time":"2021-11-16T20:33:44Z","timestamp":1637094824000},"score":1,"resource":{"primary":{"URL":"https:\/\/portlandpress.com\/bioscirep\/article\/39\/9\/BSR20192466\/220434\/Wnt-catenin-signaling-as-a-useful-therapeutic"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9]]},"references-count":81,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2019,9,30]]}},"URL":"https:\/\/doi.org\/10.1042\/bsr20192466","relation":{},"ISSN":["0144-8463","1573-4935"],"issn-type":[{"value":"0144-8463","type":"print"},{"value":"1573-4935","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2019,9]]},"published":{"date-parts":[[2019,9]]},"article-number":"BSR20192466"}}